Eosinophil infiltration and activation in nasal polyposis

Acta Oto-Laryngologica

Volumn 127, Issue 5, 2007, Pages 521-526

  Fan, Guo Kang ^a   Wang, Hualin ^a,c   Takenaka, Hiroshi ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

EG1; EG2; Eotaxin; IL 5; T cell

Indexed keywords

CD3 ANTIGEN; EOTAXIN; INTERLEUKIN 5;

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; CHEMOKINES, CC; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-5; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SINUSITIS; T-LYMPHOCYTES;

EID: 34247395811     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600951368     Document Type: Article

References (27)

1. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 2005;5:463-71.
2. Bernstein JM. The molecular biology of nasal polyposis. Curr Allergy Asthma Rep 2001;1:262-7.
3. Eliashar R, Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 2005;13:171-5.
4. Eisma RJ, Allen JS, Lafreniere D, Leonard G, Kreutzer DL. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol 1997;18:405-11.
5. Iino Y, Miyazawa T, Kakizaki K, Saigusa H, Katano H, Shiga J, et al. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps. Acta Otolaryngol 2006; 126:43-50.
6. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van-de-Rijn M, Bonventre JV, et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996;2:334-48.
7. Cook EB, Stahl JL, Lilly CM, Haley KJ, Sanchez H, Luster AD, et al. Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung. Allergy Asthma Proc 1998;19:15-22.
8. Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
9. Brown JR, Kleimberg J, Marini M, Sun G, Bellini A, Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 1998;114:137-46.
10. Molinaro RJ, Bernstein JM, Koury ST. Localization and quantitation of eotaxin mRNA in human nasal polyps. Immunol Invest 2003;32:143-54.
11. Gorski P, Wittczak T, Walusiak J, Palczynski C, Ruta U, Kuna P, et al. Eotaxin but not MCP-3 induces eosinophil influx into nasal fluid in allergic patients. Allergy 2002;57:519-28.
12. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147-74.
13. MacLean JA, Ownbey R, Luster AD. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med 1996;184:1461-9.
14. Garlisi CG, Falcone A, Kung TT, Stelts D, Pennline KJ, Beavis AJ, et al. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995;75:75-83.
15. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064-71.
16. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophils degranulation. J Immunol 1990;144:642-6.
17. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
18. Okudaira H, Mori A. Simple understanding and optimistic strategy for coping with atopic diseases. Int Arch Allergy Immunol 1998;117:11-9.
19. Fan GK, Fujieda S, Sunaga H, Tsuzuki H, Ito N, Saito H. Expression of protein p27 is associated with progression and prognosis in laryngeal cancer. Laryngoscope 1999;109:815-20.
20. Erjefalt JS, Andersson M, Greiff L, Korsgren M, Gizycki M, Jeffery PK, et al. Cytolysis and piecemeal degranulation as distinct modes of activation of mucosal eosinophils. J Allergy Clin Immunol 1998;102:286-94.
21. Rasp G, Thomas PA, Bujia J. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum. Clin Exp Allergy 1994;24:1151-6.
22. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin 5 (IL-5) regulated the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1998;73:1504-12.
23. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/CD18)-dependent manner. Immunology 1990;71: 258-65.
24. Simon H-U, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
25. Rosas M, Dijkers P, Lindemans C, Lammers JW, Koenderman L, Coffer PJ. IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with {beta}-catenin relocalization. J Leukoc Biol 2006;80:186-95.
26. Bartemes KR, Cooper KM, Drain KL, Kita H. Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functions. J Allergy Clin Immunol 2005;116:827-35.
27. Taha RA, Minshall EM, Miotto D, Shimbara A, Luster A, Hogg JC, et al. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103: 476-83.